Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Prosthetic Heart Valve Market Size, Share & Industry Trends Analysis Report By End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers), By Product (Transcatheter, Tissue, and Mechanical), By Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The Global Prosthetic Heart Valve Market size is expected to reach $13.3 billion by 2028, rising at a market growth of 10.7% CAGR during the forecast period. Materials like titanium and carbon are used to make mechanical heart valves. They are typically made up of two leaflets and a metal ring encircled by a knitted fabric ring that is sewed onto the heart in place of the native valve. Aortic and mitral replacement operations are available in a variety of models. Mechanical valves have the advantage of being extremely durable. These valves, on the other hand, provide a substrate on which blood clots can easily form. An opening through which blood flows and a device that closes and opens the orifice make up artificial heart valves. Mechanical devices made of synthetic materials and biological or tissue valves made of animal or human tissue are the two forms of artificial heart valves. Biological valves are typically employed in people over the age of 65 who are unable to take anticoagulants.
Mechanical valves are advised for individuals under the age of 40 who have a mechanical valve at another position, have had a stroke, or require double valve replacement. These valves necessitate the use of anti-coagulants by the patient. Mechanical valves can be classified into three categories based on how they open and close. A revolving ball, a tilting disk, or two semispherical hinged leaflets are examples of these systems. The first is based on a ball-in-cage design, which employs a rubber ball that oscillates within a cobalt-chromium alloy metal cage. When the valve opens, blood flows between the ball and the housing through a primary and secondary orifice. A circular disk is held in place by wire-like arms that protrude into the orifice in the tilting disk valve. The primary orifice is divided into two unequal orifices when the disk opens. A hinge mechanism connects two semicircular leaflets to the orifice enclosure in the current configuration. During the opening process, the leaflets separate, resulting in three flow zones in the center as well as on the sides. COVID-19 Impact Analysis
During the pandemic, surgeries were delayed and production of prosthetic heart valves was also decreased or suspended due to government restrictions and limitations, causing the prosthetic heart valve market to experience a drop in the growth during the first wave of COVID-19.
Coronaviruses are a wide family of SARS (severe acute respiratory syndrome) viruses that cause illnesses ranging from ordinary cold to serious respiratory illnesses. The execution of lockdown postponed the surgical operation for implanting a prosthetic heart valve as well as the manufacturing of prosthetic heart valves, resulting in gradual market disruption. Market Growth Factors:
Rising prevalence of cardiovascular diseases
With the rapidly evolving lifestyles of people across the world, the occurrence of various diseases and disorders is also rising as a result. One of the major disorders that can be caused by the changing living patterns of people is cardiovascular disease. Unhealthy food, physical inactivity, cigarette consumption, and problematic alcohol consumption are the major behavioral risk factors for heart disease and stroke.
People may experience symptoms, such as high blood pressure, high blood glucose, high blood lipids, or overweight or obesity as a result of behavioral risk factors. These intermediate risk factors are detectable in primary care settings and imply a higher risk of stroke, heart attack, heart failure, and other consequences. The rapid surge in the geriatric population
The geriatric population all over the world is significantly increasing. According to the United Nations Organization, in 2019, the world's population of people aged 65 and up totaled 703 million. In 2050, the number of geriatric people is anticipated to reach 1.5 billion. The proportion of people aged 65 and up in the global population climbed from 6% in 1990 to 9% in 2019. By 2050, that percentage is expected to climb to 16%, implying that one in every six individuals worldwide is expected to be 65 or older. In the years 2015-2020, a 65-year-old person should expect to live an additional 17 years on average over the world. Marketing Restraining Factor:
Mechanical heart valve failure occurs in various cases after the completion of an artificial heart valve transplant. Though structural damage is uncommon, infections and blood clots may necessitate the replacement of some of them. Clots can either open or seal the mechanical valve, causing stenosis, insufficiency, or a combination of the two.
Some clots can break free from the prosthetic valve and move to the arteries and blood vessels that supply the heart (coronary arteries) or the brain (carotid arteries), resulting in a stroke or heart attack. Mechanical heart valves have a higher risk of thrombotic or thromboembolic consequences.
Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.1.1 Market composition and scenario 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Competition Analysis - Global 3.1 Cardinal Matrix 3.2 Recent Industry Wide Strategic Developments 3.2.1 Approvals and Trials 3.2.2 Product Launches and Product Expansions 3.2.3 Acquisition and Mergers 3.3 Top Winning Strategies 3.3.1 Key Leading Strategies Percentage Distribution (2018-2022) 3.3.2 Key Strategic Move (Acquisitions and Mergers 2019, Mar - 2021, Oct) Leading Players Chapter 4. Global Prosthetic Heart Valve Market by End User 4.1 Global Hospitals & Cardiac Centers Market by Region 4.2 Global Ambulatory Surgical Centers & Others Market by Region Chapter 5. Global Prosthetic Heart Valve Market by Product 5.1 Global Transcatheter Market by Region 5.2 Global Tissue Market by Region 5.3 Global Mechanical Market by Region Chapter 6. Global Prosthetic Heart Valve Market by Region Chapter 7. Company Profiles 7.1 Boston Scientific Corporation 7.1.1 Company Overview 7.1.2 Financial Analysis 7.1.3 Segmental and Regional Analysis 7.1.4 Research & Development Expense 7.1.5 Recent strategies and developments 7.1.5.1 Product Launches and Product Expansions 7.1.5.2 Acquisition and Mergers 7.1.6 SWOT Analysis 7.2 Medtronic PLC 7.2.1 Company overview 7.2.2 Financial Analysis 7.2.3 Segmental and Regional Analysis 7.2.4 Research & Development Expenses 7.2.5 Recent strategies and developments 7.2.5.1 Approvals and Trials 7.2.6 SWOT Analysis 7.3 Abbott Laboratories 7.3.1 Company Overview 7.3.2 Financial Analysis 7.3.3 Segmental and Regional Analysis 7.3.4 Research & Development Expense 7.3.5 Recent strategies and developments 7.3.5.1 Product Launches and Product Expansions 7.3.5.2 Acquisition and Mergers 7.3.5.3 Approvals and Trials 7.3.6 SWOT Analysis 7.4 Meril Life Sciences Private Limited 7.4.1 Company Overview 7.4.2 Recent strategies and developments 7.4.2.1 Product Launches and Product Expansions 7.5 Colibri Heart Valve LLC 7.5.1 Company Overview 7.6 Artivion, Inc. (CryoLife, Inc.) 7.6.1 Company Overview 7.6.2 Financial Analysis 7.6.3 Segmental and Regional Analysis 7.6.4 Research & Development Expenses 7.6.5 Recent strategies and developments 7.6.5.1 Acquisition and Mergers 7.7 TTK Healthcare Limited 7.7.1 Company Overview 7.7.2 Financial Analysis 7.7.3 Segmental and Regional Analysis 7.7.4 Research & Development Expenses 7.8 Edwards Lifesciences Corporation 7.8.1 Company Overview 7.8.2 Financial Analysis 7.8.3 Regional Analysis 7.8.4 Research & Development Expenses 7.8.5 Recent strategies and developments 7.8.5.1 Acquisition and Mergers 7.8.5.2 Approvals and Trials 7.9 JenaValve Technology, Inc. 7.9.1 Company Overview 7.9.2 Recent strategies and developments 7.9.2.1 Geographical Expansions 7.10. Micro Interventional Devices, Inc. 7.10.1 Company Overview 7.10.2 Recent strategies and developments 7.10.2.1 Approvals and Trials
For more information about this report visit https://www.researchandmarkets.com/r/1j2fgo
The $18 billion market for colon-cancer screening perfectly illustrates the difference between innovation and hype. It has implications for Exact Sciences , Guardant Health and others setting their sights on the market. A number of Wall Street analysts say that liquid biopsies can claim a significant share of the colon-cancer-screening market.
Yahoo Finance's Brian Cheung discusses reports that a depression drug from Axsome Therapeutics has gotten FDA clearance.
The Food and Drug Administration approved a new depression pill from Axsome Therapeutics on Friday, and AXSM stock catapulted higher.
When President Joe Biden signed the CHIPS Act of 2022 into law on Aug. 9, it provided some good news for a number of chip stocks.
(Bloomberg) -- Gazprom PJSC will stop delivering natural gas to Europe through its main pipeline for three days, further squeezing energy supplies just as Germany is trying to build up stocks for the winter.European benchmark futures soared as much as 9% after the Russian producer said it won’t ship any gas to Germany via the Nord Stream pipeline from Aug. 31 through Sept. 2 because of maintenance. The work will involve the only functioning turbine that can pump gas into the link.The European ga
U.S. based monkeypox vaccine manufacturer targets December for first batch of doses for delivery.
Statement Highlights: A “state of the science” review details the most reported symptoms of 6 cardiovascular diseases (CVDs): heart attack, heart failure, valve disease, stroke, heart rhythm disorders, and peripheral artery and vein disease (PAD and...
Prices at the pump have fallen again, but the summer decline is mostly over, according to industry watchers.
A Seattle CEO who announced in 2015 that he was giving himself a drastic pay cut to help cover the cost of big raises for his employees has announced his resignation.
The Biden administration is planning to stop paying for Covid vaccines and treatments, a move that could buoy some Covid stocks.
(Bloomberg Law) -- The Consumer Financial Protection Bureau asked a federal judge to force Block Inc. to fully comply with a pair of investigative demands related to its Cash App payments tool.The CFPB’s petition, filed Thursday, urged the US District Court for the Northern District of California to enforce a civil investigative demand. Block, the digital payments company led by CEO Jack Dorsey, has yet to provide all of the documents and data the CFPB requested in August 2020 and August 2021, t
Households can expect to pay more to heat their homes this winter. “Natural gas futures prices are more than double what they were one year ago,” according to Andy Lipow of Lipow Oil Associates.
Most Americans have at least heard of a 401(k) plan, but there is another tax-advantaged workplace retirement plan out there - the 403(b). A 403(b) operates similarly to a 401(k), but is generally only available to public sector employees and … Continue reading → The post IRS May Close This RMD Loophole appeared first on SmartAsset Blog.
Yahoo Finance's Julie Hyman and Brian Sozzi discuss DoorDash and Walmart ending their partnership next month.
The World Health Organization (WHO) has published its first guideline for Ebola virus disease therapeutics, with new recommendations for using two monoclonal antibodies. Following a systematic review and meta-analysis, WHO recommended two monoclonal antibody treatments, Ebanga (Ansuvimab, mAb114) and Inmazeb (REGN-EB3). Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Inmazeb became the first treatment for the ebola virus when it received FDA approval in October 2020. Merck & Co Inc's (NYSE: MRK)
Enterprise Products Partners, Energy Transfer and Magellan Midstream Partners have been highlighted in this Industry Outlook article.
The telecom giant is reportedly reneging on its promise of a six-month extension of its work-from-home plan. It refuses to discuss a hybrid policy, one worker says.
The drug, which can take effect within a week, uses a different mechanism than traditional treatments for depression.
At a time when intellectual-property rights power TV, movies and theme parks, three companies just lost out on the biggest property that was still out there.
The Federal Energy Regulatory Commission filing could mean that Berkshire Hathaway will continue to increase its stake in Occidental.